Wellington Management Group
IPSC icon

Wellington Management Group’s Century Therapeutics IPSC Stock Holding History

Wellington Management Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-166,123
Closed -$284K – 1989
2024
Q3 		$284K Buy
+166,123
New +$325K ﹤0.01% 1872
2021
Q3 		– Sell
-16,821
Closed -$494K – 2204
2021
Q2 		$494K Buy
+16,821
New +$427K ﹤0.01% 1920

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group's IPSC Position: Q4 2024 in Review

Wellington Management Group sold out of Century Therapeutics (IPSC) in Q4 2024, closing a stake of 166,123 shares — an estimated $284K sold.

Wellington Management Group first reported a position in IPSC in Q2 2021 and held it in 2 quarters. The position peaked at $494K in Q2 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q4 2024.

  • Wellington Management Group reported no remaining Century Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Wellington Management Group sold 166,123 Century Therapeutics shares in Q4 2024, an estimated $284K.
  • Wellington Management Group first reported a position in Century Therapeutics in Q2 2021 and held it in 2 quarters.
  • Wellington Management Group's Century Therapeutics position peaked at $494K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2024.

Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.